Policy-Advocacy

HHS and ASN Announce Members of Newly Formed KidneyX Innovation Accelerator Steering Committee

KidneyX_main.jpgThe US Department of Health and Human Services (HHS) Office of the Chief Technology Officer and ASN announced a diverse group of experts for the new KidneyX Innovation Accelerator steering committee, which will play a critical role in recommending a five-year strategic plan for the initiative, as well as providing guidance for all KidneyX activities and outreach.

Washington Post Opinion Piece Highlights Bipartisan Agreement on Opportunities for Improvement in Organ Procurement

In a Friday, October 4, Washington Post opinion piece, former White House Office of Science and Technology Policy staffer Jennifer Erickson calls for a reform of the current United States organ procurement system.

Medicare Makes Bold Move to Increase Access to Transplants

In a bold move to increase organ transplantation, the Centers for Medicare and Medicaid Services (CMS or Medicare) has finalized a proposal “to remove the requirements at § 482.82 (conditions of participation for transplant centers) that require transplant centers to submit clinical experience, outcomes, and other data in order to obtain Medicare re-approval.” The American Society of Nephrology (ASN) and other members of the kidney community advocated for this change to reduce the unintended consequences associated with the re-approval process.

ASN Weighs in on ESRD Treatment Choice Model in Letter to CMS

Reducing the benchmark for the combined home dialysis and transplant rate and allowing for incremental achievement of the benchmark, incentivizing and investing wisely to ensure needed practice transformation, and delaying the start date of the ESRD Treatment Choice Model (ETC) until April 2020 are among the recommendations for adjustments to the model set forth in a letter sent to CMS Administrator Seema Verma on behalf of ASN and its members from President Mark E. Rosenberg, MD, FASN.

ASN, the National Kidney Foundation, and the Renal Physicians Association Send Joint Response to CMS Regarding ESRD Treatment Choice Model

In a joint letter to the Centers for Medicare and Medicaid Services Administrator (CMS) Seema Verma, ASN, the National Kidney Foundation (NKF), and the Renal Physicians Association (RPA) laud the Trump administration for its “ambitious agenda for kidney health” and identify five principles the organizations state will lead to “better patient outcomes that should be supported in the proposed ETC Model.”

The following five principles are included in the organizations’ letter to CMS:

Patients Continue to Urge the Senate Support KidneyX Appropriations in New Al.com Op-ed

Following a recent letter to the editor in the Kansas City Star, kidney patients continue to urge their congressional representatives to support KidneyX during the Senate appropriations process.

Joint ASPN/ASN Statement sent to the House Oversight Committee criticizing the ending of the deferred medical action policy for immigrants

On Monday September 2nd, the Trump Administration announced a change to a policy that allowed immigrants to receive a temporary reprieve from deportation while receiving life-savings medical care in the US.

A New Report From the Kidney Health Initiative Targets Innovations In Fluid Management

Fluid management is an area ripe for innovation that has a significant impact on the quality of life of people with kidney failure. The Kidney Health Initiative (KHI) recently released a supplement to its Technology Roadmap for Innovative Approaches to Renal Replacement Therapy entitled Fostering Innovation in Fluid Management.

ASN Policy Q&A on the Advancing American Kidney Health initiative: Part 2

In order to double the number of kidneys available for transplant by 2030, the Administration is looking to increase the utilization of available organs from both deceased and living donors in multiple ways including, but not limited to:...

Letter to the Editor in Kansas City Star calls for Senate action on kidney health, KidneyX appropriations

For nearly 50 years kidney disease, one of the most deadly and costly chronic diseases has been overlooked by government, healthcare professionals, and the public—until now.

Pages